- decreased circulating LDL cholesterol level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased circulating calcium level / IMPC
- decreased circulating glycerol level / IMPC
- decreased circulating iron level / IMPC
- decreased circulating cholesterol level / IMPC
- increased circulating aspartate transaminase level / IMPC
- thrombocytosis / IMPC
- decreased circulating total protein level / IMPC
- increased circulating amylase level / IMPC
C57BL/6N-Sidt2em1(IMPC)Wtsi/WtsiH
Status | Available to order |
EMMA ID | EM:13877 |
International strain name | C57BL/6N-Sidt2em1(IMPC)Wtsi/WtsiH |
Alternative name | |
Strain type | Endonuclease-mediated |
Allele/Transgene symbol | Sidt2em1(IMPC)Wtsi |
Gene/Transgene symbol | Sidt2 |
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- increased circulating amylase level / IMPC
- decreased circulating calcium level / IMPC
- decreased circulating iron level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased circulating total protein level / IMPC
- decreased circulating glycerol level / IMPC
- increased circulating aspartate transaminase level / IMPC
- decreased circulating cholesterol level / IMPC
- thrombocytosis / IMPC
- decreased circulating LDL cholesterol level / IMPC
MGI phenotypes (gene matching)
- abnormal liver morphology / MGI
- abnormal hepatocyte morphology / MGI
- decreased body weight / MGI
- decreased body size / MGI
- increased circulating triglyceride level / MGI
- hepatic necrosis / MGI
- liver inflammation / MGI
- no abnormal phenotype detected / MGI
- hepatic steatosis / MGI
- decreased circulating insulin level / MGI
- increased circulating alanine transaminase level / MGI
- liver fibrosis / MGI
- abnormal insulin secretion / MGI
- increased pancreatic beta cell number / MGI
- abnormal pancreatic beta cell morphology / MGI
- impaired glucose tolerance / MGI
- increased circulating aspartate transaminase level / MGI
- homeostasis/metabolism phenotype / MGI
- increased circulating glucose level / MGI
- increased liver triglyceride level / MGI
- abnormal endoplasmic reticulum morphology / MGI
- increased liver free fatty acids level / MGI
- increased endoplasmic reticulum stress / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).